1. Home
  2. GSIW vs EVAX Comparison

GSIW vs EVAX Comparison

Compare GSIW & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • EVAX
  • Stock Information
  • Founded
  • GSIW 2016
  • EVAX 2008
  • Country
  • GSIW Hong Kong
  • EVAX Denmark
  • Employees
  • GSIW N/A
  • EVAX N/A
  • Industry
  • GSIW
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GSIW
  • EVAX Health Care
  • Exchange
  • GSIW Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • GSIW 8.1M
  • EVAX 17.8M
  • IPO Year
  • GSIW 2023
  • EVAX 2021
  • Fundamental
  • Price
  • GSIW $0.14
  • EVAX $2.90
  • Analyst Decision
  • GSIW
  • EVAX Strong Buy
  • Analyst Count
  • GSIW 0
  • EVAX 2
  • Target Price
  • GSIW N/A
  • EVAX $10.00
  • AVG Volume (30 Days)
  • GSIW 16.9M
  • EVAX 89.0K
  • Earning Date
  • GSIW 01-01-0001
  • EVAX 10-30-2025
  • Dividend Yield
  • GSIW N/A
  • EVAX N/A
  • EPS Growth
  • GSIW N/A
  • EVAX N/A
  • EPS
  • GSIW N/A
  • EVAX N/A
  • Revenue
  • GSIW $5,368,221.00
  • EVAX $3,176,000.00
  • Revenue This Year
  • GSIW N/A
  • EVAX N/A
  • Revenue Next Year
  • GSIW N/A
  • EVAX N/A
  • P/E Ratio
  • GSIW N/A
  • EVAX N/A
  • Revenue Growth
  • GSIW 283.23
  • EVAX 1042.45
  • 52 Week Low
  • GSIW $0.09
  • EVAX $1.20
  • 52 Week High
  • GSIW $8.35
  • EVAX $17.20
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 40.30
  • EVAX 50.88
  • Support Level
  • GSIW $0.09
  • EVAX $2.71
  • Resistance Level
  • GSIW $0.20
  • EVAX $3.04
  • Average True Range (ATR)
  • GSIW 0.02
  • EVAX 0.20
  • MACD
  • GSIW 0.03
  • EVAX -0.01
  • Stochastic Oscillator
  • GSIW 50.43
  • EVAX 55.97

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: